denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Handling Challenging Questions in the Management of CML
Hematology Disease Topics & Pathways:
Diseases, CML, Myeloid Malignancies, Clinically relevant
Session: Handling Challenging Questions in the Management of CML
Hematology Disease Topics & Pathways:
Diseases, CML, Myeloid Malignancies, Clinically relevant
Saturday, December 5, 2020, 11:55 AM-12:00 PM
Disclosures: Rea: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees; Pfizer: Honoraria, Membership on an entity's Board of Directors or advisory committees; Incyte: Honoraria, Membership on an entity's Board of Directors or advisory committees.
OffLabel Disclosure: I may talk about discontinuation of CML TKI regardless of type of TKI, only one has TFR in its label